| Ident. | Authors (with country if any) | Title |
|---|
| 000626 (2000) |
Eric J. Topola ; J. Donald Eastonb ; Pierre Amarencoc ; Robert Califfd ; Robert Harringtond ; Carmen Graffagninod ; Stephen Davise ; H. C. Dienerf ; James Fergusong ; Desmond Fitzgeraldh ; Ashfaq Shuaibi ; Peter J. Koudstaalj ; Pierre Therouxk ; Frans Van De Werfl ; James T. Willersonm ; Robert Chann ; Robert Samuelsn ; Bernard Ilsonn ; Jeffrey Granettn | Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial |
| 000687 (2005) |
Marcus D. Flather [Royaume-Uni] ; Marcelo C. Shibata [Royaume-Uni, Canada] ; Andrew J. S. Coats [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Aleksandr Parkhomenko [Ukraine] ; Joszef Borbola [Hongrie] ; Alain Cohen-Solal [France] ; Dan Dumitrascu [Roumanie] ; Roberto Ferrari [Italie] ; Philippe Lechat [France] ; Jordi Soler-Soler [Espagne] ; Luigi Tavazzi [Italie] ; Lenka Spinarova [République tchèque] ; Jiri Toman [République tchèque] ; Michael Bo Hm [Allemagne] ; Stefan D. Anker [Allemagne] ; Simon G. Thompson [Royaume-Uni] ; Philip A. Poole-Wilson [Royaume-Uni] | Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) |
| 000692 (1998) |
Werner Hacke [Allemagne] ; Markku Kaste [Finlande] ; Cesare Fieschi [Italie] ; Rdiger Von Kummer [Allemagne] ; Antoni Davalos [Espagne] ; Dieter Meier [Allemagne] ; Vincent Larrue [France] ; Erich Bluhmki [Allemagne] ; Stephen Davis [Australie] ; Geoffrey Donnan [Australie] ; Dietmar Schneider [Allemagne] ; Exuperio Diez-Tejedor [Espagne] ; Paul Trouillas [France] | Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) |
| 000769 (2000) |
Robert A. De Man ; Patrick Marcellin ; Flavio Habal ; Paul Desmond ; Teresa Wright ; Toby Rose ; Regina Jurewicz ; Clarence Young | A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen–positive hepatitis B |
| 000779 (2003) |
Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Birol Emir ; Vera Mastey ; Ponni Subbiah [États-Unis] ; Ponni The Donepezil Msad Study Investigators Group [Canada] | Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden |
| 000B14 (2005) |
Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Yikang Xu [États-Unis] ; John R. Ieni [États-Unis] ; Elias M. Schwam [États-Unis] | Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo‐controlled trial |
| 000B16 (2004) |
Paul Kiritze Topor [France] ; Dominique Huas [France] ; Claude Rosenzweig [France] ; Sylvie Comte [France] ; Franc Ois Paille [France] ; Philippe Lehert [Australie] | A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE |
| 000B63 (2013) |
J. Yale [Canada] ; G. Bakris [États-Unis] ; B. Cariou [France] ; D. Yue [Australie] ; E. David-Neto [Brésil] ; L. Xi [États-Unis] ; K. Figueroa [États-Unis] ; E. Wajs [Belgique] ; K. Usiskin [États-Unis] ; G. Meininger [États-Unis] | Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease |
| 001054 (2011) |
Michael Weber [Allemagne] ; Deepak L. Bhatt [États-Unis] ; Danielle M. Brennan [États-Unis] ; Graeme J. Hankey [Australie] ; Steven R. Steinhubl [Suisse] ; S Claiborne Johnston [États-Unis] ; Gilles Montalescot [France] ; Koon-Hou Mak [République populaire de Chine] ; Keith A A. Fox [Royaume-Uni] ; Donald J. Easton [États-Unis] ; Eric J. Topol [États-Unis] ; Christian W. Hamm [Allemagne] | High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial |
| 001137 (2008) |
O. Bruyere [Belgique] ; D. Delferriere [Belgique] ; C. Roux [France] ; J D Wark [Australie] ; T. Spector [Royaume-Uni] ; J-P Devogelaer [Belgique] ; K. Brixen [Danemark] ; S. Adami [Italie] ; J. Fechtenbaum [France] ; S. Kolta [France] ; J-Y Reginster [Belgique] | Effects of strontium ranelate on spinal osteoarthritis progression |
| 001354 (2005) |
A. B. Gottlieb [Suisse] ; C. E. M. Griffiths [Suisse] ; V. C. Ho [Suisse] ; M. Lahfa [Suisse] ; U. Mrowietz [Suisse] ; D. F. Murrell [Suisse] ; J-P. Ortonne [Suisse] ; G. Todd [Suisse] ; R. Cherill [Suisse] ; I. Marks [Suisse] ; S. Emady-Azar [Suisse] ; C. F. Paul [Suisse] | Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: a double‐blind, multicentre, randomized, dose‐finding trial |
| 001548 (2010) |
S. Czernichow [Australie, France] ; C. M. Y. Lee [Australie] ; F. Barzi [Australie] ; J. R. Greenfield [Australie] ; L. A. Baur [Australie] ; J. Chalmers [Australie] ; M. Woodward [Australie] ; R. R. Huxley [Australie] | Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta‐analysis of randomized controlled trials |
| 001639 (2011) |
Stephane Heritier [Australie] ; Serigne N. Lô [Australie] ; Caroline C. Morgan [France] | An adaptive confirmatory trial with interim treatment selection: Practical experiences and unbalanced randomization |
| 001773 (2006) |
Wolfram Sterry [Allemagne] ; Georg Stingl [Autriche] ; Richard G. B. Langley [Canada] ; Hugh Zacharie [Danemark] ; Morad Lahfa [France] ; Alberto Giannetti [Italie] ; Carlos Ferrándiz [Espagne] ; Rodney Sinclair [Australie] ; Jean-Hilaire Saurat [Suisse] | CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo‐controlled trial |
| 001E65 (2006) |
L. Dubertret ; W. Sterry ; J. D. Bos ; S. Chimenti ; S. Shumack ; C. G. Larsen ; N. H. Shear ; K. A. Papp | CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from a phase III international randomized, placebo‐controlled trial |
| 001F14 (2000) |
Kennedy R. Lees [Royaume-Uni] ; Kjell Asplund [Suède] ; Antonio Carolei [Italie] ; Stephen M. Davis [Australie] ; Hans-Christoph Diener [Allemagne] ; Markku Kaste [Finlande] ; Jean-Marc Orgogozo [France] ; John Whitehead [Royaume-Uni] | Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial |
| 002257 (2013) |
C. J. Lessard [États-Unis] ; H. Li [États-Unis] ; J. A. Ice [États-Unis] ; I. Adrianto [États-Unis] ; R. Jonsson [Norvège] ; G. G. Illei [États-Unis] ; M. Rischmueller [Australie] ; G. Nordmark [Suède] ; X. Mariette [France] ; C. Miceli-Richard [France] ; M. Wahren Herlenius [Suède] ; T. Witte [Allemagne] ; M. Brennan ; R. Omdal [Norvège] ; P. M. Gaffney [États-Unis] ; J. A. Lessard [États-Unis] ; L. Rönnblom [Suède] ; W.-F. Ng [Royaume-Uni] ; N. Rhodus ; B. Segal ; R. H. Scofield [États-Unis] ; J. A. James [États-Unis] ; J.-M. Anaya [Colombie] ; C. G. Montgomery [États-Unis] ; J. B. Harley [États-Unis] ; K. Moser Sivils [États-Unis] | OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci |
| 002370 (2012) |
Bertram Pitt [États-Unis] ; Gerasimos Filippatos [Grèce] ; Mihai Gheorghiade [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France] | Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease |
| 002477 (1997) |
Laurence J. Sullivan [Australie] ; Fiona Mccurrach [Australie] ; Sharon Lee [Australie] ; Hugh R. Taylor [Australie] ; Maurizio Rolando [Italie] ; Christianne Marechal-Courtois [Belgique] ; Catherine Creuzot-Garcher [France] ; David L. Easty [Royaume-Uni] ; Constantios Karabatsas [Royaume-Uni] ; M. Bingh Hoh [Royaume-Uni] ; Cristoph Faschinger [Autriche] ; Laurent Laroche [France] | Efficacy and Safety of 0.3% Carbomer Gel Compared to Placebo in Patients with Moderate-to-Severe Dry Eye Syndrome |
| 002677 (2013) |
Michel Komajda [France] ; Michael Böhm [Allemagne] ; Jeffrey Borer [États-Unis] ; Ian Ford [Royaume-Uni] ; Henry Krum [Australie] ; Adrian Tase [Roumanie] ; Luigi Tavazzi [Italie] ; Karl Swedberg [Suède] | Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure |
| 002894 (2008) |
C. Lloret-Linares [France] ; J. R. Greenfield [France] ; S. Czernichow [France] | Effect of weight‐reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review |
